BioPorto A/S (BIOPOR.CO) Return on Assets (ROA)
Market Cap: $610.11M
Avg Volume: 369.91K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
BioPorto A/S Return on Assets (ROA) Summary
BioPorto A/S's ROA indicates the return generated on the company's assets:
- Annual: -62.72%
- Quarterly: -19.18%
- TTM: -56.29%
What is Return on Assets (ROA)?
Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.
Related Metrics
Other important metrics to assess BioPorto A/S's profitability include:
- ROE (Return on Equity) - measures the return generated on shareholders' equity:
- Annual: -93.63%
- Quarterly: -24.13%
- TTM: -83.62%
- ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
- Annual: -82.14%
- Quarterly: -22.17%
- TTM: -69.24%
- Return on Tangible Assets - measures the return generated on the company's tangible assets:
- Annual: -63.04%
- Quarterly: -19.23%
- TTM: -56.46%
- Profit Margin - shows the percentage of revenue that has turned into profit:
- Annual: -181.95%
- Quarterly: -215.65%
- TTM: -175.62%
These metrics provide insights into BioPorto A/S's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.
Annual ROA
-62.72%
Quarterly ROA
-19.18%
TTM ROA
-56.29%
BioPorto A/S Historical ROA
Historical ROE
Historical ROIC
Historical Profit Margin
Historical Return on Tangible Assets
BioPorto A/S Historical Profitability Metrics
The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2023.
| Year | ROA | ROE | ROIC | Profit Margin | Return on Tangible Assets |
|---|---|---|---|---|---|
| 2023 | -62.72% | -93.63% | -82.14% | -181.95% | -63.04% |
| 2022 | -69.88% | -108.12% | -89.66% | -262.08% | -70.38% |
| 2021 | -70.29% | -124.26% | -98.45% | -235.48% | -71.21% |
| 2020 | -43.88% | -61.01% | -52.28% | -265.31% | -44.25% |
| 2019 | -163.16% | -275.03% | -232.39% | -261.60% | -168.14% |
| 2018 | -57.47% | -67.70% | -66.87% | -146.25% | -58.69% |
| 2017 | -49.15% | -57.51% | -55.57% | -128.18% | -50.40% |
| 2016 | -45.02% | -51.48% | -50.15% | -110.04% | -46.83% |
| 2015 | -21.91% | -24.12% | -23.61% | -52.65% | -22.16% |
| 2014 | -34.71% | -45.06% | -45.37% | -69.10% | -34.90% |
Related Metrics
Explore detailed financial metrics and analysis for BIOPOR.CO.